Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function

James E Neffendorf, Tracey Mare, Andrew R H Simpson, Cristina Soare, Varo Kirthi, Claire C Sharpe, Timothy L Jackson

Research output: Contribution to journalArticlepeer-review

Abstract

This study did not find any clinically significant change in serum markers of renal function in the one month after intravitreal ranibizumab or aflibercept. It did, however, find a non-significant rise in creatinine with aflibercept, that was not seen with ranibizumab.
Original languageEnglish
Pages (from-to)1770-1772
Number of pages3
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Volume38
Issue number7
Early online date10 Feb 2023
DOIs
Publication statusPublished - 30 Jun 2023

Fingerprint

Dive into the research topics of 'Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function'. Together they form a unique fingerprint.

Cite this